Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance

Pediatric Blood and Cancer

Volumn 45, Issue 3, 2005, Pages 347-350

  Jubinsky, Paul T ^a   Rashid, N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anti CD20 antibody; Autoimmunity; Diabetes; Hemolytic anemia; Rituximab; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; BLOCKING ANTIBODY; CD20 ANTIBODY; COTRIMOXAZOLE; IMMUNOGLOBULIN; INSULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

ADOLESCENT; ADOLESCENT DISEASE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CHILDHOOD DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; GLUCOSE INTOLERANCE; HUMAN; MALE; PRIORITY JOURNAL; RARE DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; GLUCOSE INTOLERANCE; HUMANS; IMMUNOLOGIC FACTORS; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SYNDROME;

EID: 23044459450     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20312     Document Type: Article

References (22)

1. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: An 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) 1981;282:2023-2027.
2. Sokol RJ, Hewitt S, Stamps BK. Autoimmune hemolysis: Mixed warm and cold antibody type. Acta Haematol 1983;69:266-274.
3. Shulman IA, Branch DR, Nelson JM, et al. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA 1985;253: 1746-1748.
4. Panzarino V, Estrada J, Benson K, et al. Autoimmune hemolytic anemia after Kawasaki disease in a child. Int J Hematol 1993;57: 259-263.
5. Sheth SS, Karande SC, Nadkarni VB, et al. Autoimmune hemolytic anemia-Mixed type. Indian Pediatr 1991;28:303-304.
6. Eliachar E, Tassy R, Homberg JC, et al. Acute hemolytic anemia due to mixed autoantibodies followed by a cure. Ann Pediatr (Paris) 1968;15:482-484.
7. Medrea B, Tanasescu R, Lupu E, et al. Evans syndrome and diabetes mellitus, sequelae of viral hepatitis. Mars Med 1968; 105:31-34.
8. Plevova P, Cermakova R, Lochmanova A, et al. Evans syndrome in a child with diabetes mellitus. Pediatr Hematol Oncol 1998;15: 353-357.
9. Savasan S, Worrier I, Ravindranath Y. The spectrum of Evans syndrome. Arch Dis Child 1997;77:245-248.
10. Morooka S, Kamii K, lizuka T, et al. Case of juvenile diabetes mellitus accompanied by autoimmune hemolytic anemia. Naika 1968;22:1515-1518.
11. Maiz L, Munoz A, Maldonado S, et al. Bronchiolitis obliterons organizing pneumonia associated with Evans syndrome. Respiration 2001;68:631-634.
12. Ertem M, Uysal Z, Yavuz G, et al. Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease. Pediatr Hematol Oncol 2000;17:181-185.
13. Perrotta S, Locatelli F, La Manna A, et al. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol 2002;116:465-467.
14. Freedman J, Lim FC, Musclow E, et al. Autoimmune hemolytic anemia with concurrence of warm and cold red cell autoantibodies and a warm hemolysin. Transfusion 1985;25:368-372.
15. Zaja F, Iacona I, Masolini P, et al. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica 2002;87:189-195.
16. McMahon C, Babu L, Hodgson A, et al. Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)? Br J Haematol 2002;117:480-483.
17. Quartier P, Brethon B, Philippet P, et al. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001; 358:1511-1513.
18. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857-3861.
19. Morselli M, Luppi M, Potenza L, et al. Mixed warm and cold autoimmune hemolytic anemia: Complete recovery after 2 courses of rituximab treatment. Blood 2002;99:3478-3479.
20. Silverman GJ, Weisman S. Rituximab therapy and autoimmune disorders: Prospects for anti-B cell therapy. Arthritis Rheum 2003; 48:1484-1492.
21. Stasi R, Pagano A, Stipa E, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98:952-957.
22. Cooper N, Stasi R, Cunningham-Rundles S, et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004;125:232-239.